Evidence map›Paper›PMID 31311187›Full record

ArticleCancers2019

Function of p21 (Cip1/Waf1/

Nina-Naomi Kreis, Alexandra Friemel, Andreas Ritter, Susanne Roth, Udo Rolle, Frank Louwen, Juping Yuan

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nina-Naomi KreisDepartment of Gynecology and Obstetrics, School of Medicine, J. W. Goethe-University, D-60590 Frankfurt, Germany. Nina-Naomi.Kreis@kgu.de.
Alexandra FriemelDepartment of Gynecology and Obstetrics, School of Medicine, J. W. Goethe-University, D-60590 Frankfurt, Germany.
Andreas RitterDepartment of Gynecology and Obstetrics, School of Medicine, J. W. Goethe-University, D-60590 Frankfurt, Germany.
Susanne RothDepartment of Gynecology and Obstetrics, School of Medicine, J. W. Goethe-University, D-60590 Frankfurt, Germany.
Udo RolleDepartment of Pediatric Surgery and Pediatric Urology, School of Medicine, J. W. Goethe-University, D-60590 Frankfurt, Germany.
Frank LouwenDepartment of Gynecology and Obstetrics, School of Medicine, J. W. Goethe-University, D-60590 Frankfurt, Germany.
Juping YuanDepartment of Gynecology and Obstetrics, School of Medicine, J. W. Goethe-University, D-60590 Frankfurt, Germany.
Goethe University Frankfurt · DE

Funding

Deutsche Forschungsgemeinschaft project number 390921723
6 · The paper itself

Abstract

Tumor progression and pregnancy have several features in common. Tumor cells and placental trophoblasts share many signaling pathways involved in migration and invasion. Preeclampsia, associated with impaired differentiation and migration of trophoblastic cells, is an unpredictable and unpreventable disease leading to maternal and perinatal mortality and morbidity. Like in tumor cells, most pathways, in which p21 is involved, are deregulated in trophoblasts of preeclamptic placentas. The aim of the present study was to enlighten p21's role in tumorigenic choriocarcinoma and trophoblastic cell lines. We show that knockdown of p21 induces defects in chromosome movement during mitosis, though hardly affecting proliferation and cell cycle distribution. Moreover, suppression of p21 compromises the migration and invasion capability of various trophoblastic and cancer cell lines mediated by, at least partially, a reduction of the extracellular signal-regulated kinase 3, identified using transcriptome-wide profiling, real-time PCR, and Western blot. Further analyses show that downregulation of p21 is associated with reduced matrix metalloproteinase 2 and tissue inhibitor of metalloproteinases 2. This work evinces that p21 is involved in chromosome movement during mitosis as well as in the motility and invasion capacity of trophoblastic and cancer cell lines.

Indexed as

CDKN1AERK3/MAPK6invasionMMP2p21TIMP2trophoblastic cell lines

Identifiers

PMID31311187
PMCPMC6678555
OpenAlexW2959779601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.